Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00508235 · ClinicalTrials.gov registry record
Quality of Friendships in Children With Neurofibromatosis
A clinical trial of Neurofibromatosis, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 61
- Enrollment target
- 1
- Study location
NCT00508235: Completed study of Neurofibromatosis, sponsored by M.D. Anderson Cancer Center.
NCT00508235 is a study of Neurofibromatosis that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 61 participants, below the 117-participant average among 5 other Neurofibromatosis trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00508235, a study of Neurofibromatosis, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine if children with a higher disease severity have lower quality friendships than children who are less severely affected and children who are unaffected. Researchers will test the hypothesis that the quality of friendships is inversely related to their disease severity. Specific Aims: 1. To use the FQQ to determine if the quality of friendships in children with NF1 is lower than the quality of friendships in unaffected children. 2. To use a disease severity scale and the FQQ to determine if children who are less severely affected have higher friendship qualities than children who are more severely affected.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
Study Locations (1)
Texas
- U.T.M.D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-07 |
What the finished NCT00508235 record still lists
NCT00508235 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 117-participant average among 5 other Neurofibromatosis trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Neurofibromatosis appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.
NCT00508235 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00508235 about?
NCT00508235 is a clinical study titled "Quality of Friendships in Children With Neurofibromatosis". The aim of this study is to determine if children with a higher disease severity have lower quality friendships than children who are less severely affected and children who are unaffected. Researchers will test the hypothesis that the quality of friendships is inversely related to their disease sev...
What is the current status of trial NCT00508235?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2004-12. Estimated completion is 2009-07.
What conditions does trial NCT00508235 study?
This clinical trial studies the following conditions: Neurofibromatosis.
What interventions are being tested in trial NCT00508235?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00508235?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00508235 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurofibromatosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Natural History Study of Patients With Neurofibromatosis Type 2
RECRUITING
-
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
RECRUITING · Phase 1
-
Validating Pain Scales in Children and Young Adults
COMPLETED
-
Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
COMPLETED · Phase 1
-
Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia